Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 48 EP applications Christopher Stuart Casley has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12711727

COLOR MODIFICATION OF SIZED FABRIC

IPC classification:
D06P 5/15, D06P 5/13
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12722991

COMPOSITIONS AND METHODS COMPRISING SERINE PROTEASE VARIANTS

IPC classification:
C12N 15/57, C12N 9/54
Applicant:
Danisco US Inc.
Applicant:
The Procter & Gamble Company
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12796229

COMBINATION PEPTIDE-NANOPARTICLES AND DELIVERY SYSTEMS INCORPORATING SAME

IPC classification:
A61K 9/14
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12728233

DISCRIMINATION OF BLOOD TYPE VARIANTS

IPC classification:
C12Q 1/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12826807

INSECTICIDAL LIPID AGENTS ISOLATED FROM ENTOMOPATHOGENIC FUNGI AND USES THEREOF

IPC classification:
A01N 63/04, A01N 37/44, A01H 15/00, C12N 1/14, C07C 229/22, C07C 227/40
Applicant:
Biotelliga Holdings Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756725

NANOPARTICLE-PEPTIDE COMPOSITIONS

IPC classification:
A61K 47/48, A61P 35/00, A61P 31/00
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12768753

NANOPARTICLE TUMOUR VACCINES

IPC classification:
A61K 47/48, A61P 35/00
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14167563

In vivo incorporation of alkynyl amino acids into proteins in eubacteria

IPC classification:
A61K 47/48, C12P 21/02, C12N 15/54, C12N 15/12, C12N 9/22, C12N 9/10
Applicant:
The Scripps Research Institute
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13167128

Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13167127

Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13167130

Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12799484

ENZYME COCKTAILS PREPARED FROM MIXED CULTURES

IPC classification:
C12P 39/00, C12P 7/10, C12P 7/08, C12P 7/06
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14167479

In vivo incorporation of unnatural amino acids

IPC classification:
C12P 21/02, C12P 21/00, C12P 19/26, C12P 13/22, C12P 13/04, C12P 13/00, C12N 15/67, C12N 9/00, C07K 14/00
Applicant:
University of California
Applicant:
The Scripps Research Institute
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
The patent has been granted
EP14177958

Glucoamylase variants with altered properties

IPC classification:
C12P 19/14, C12P 7/06, C12N 15/80, C12N 15/56, C12N 9/34, C12N 1/15
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
The patent has been granted
EP14171211

Unnatural reactive amino acid genetic code additions

IPC classification:
A61K 38/17, G01N 33/53, C12N 15/85, C12N 15/67, C12N 9/00, C12N 5/00
Applicant:
The Scripps Research Institute
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13711608

TRANSGENIC ANIMAL MODEL OF MOOD DISORDERS

IPC classification:
A01K 67/027, G01N 33/68, C12N 15/85, C07K 14/475
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
The patent has been granted
EP14189403

Production of thermolysin and variants thereof, and use in liquid detergents

IPC classification:
C12N 9/54, C11D 3/386
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14194373

In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastoris

IPC classification:
C12P 21/02, C12N 15/81, C12N 1/19, C07K 16/00
Applicant:
The Scripps Research Institute
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13792210

COMPOSITIONS AND METHODS COMPRISING THERMOLYSIN PROTEASE VARIANTS

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13165441

Alpha-glucanase and oral care composition containing the same

IPC classification:
C12N 9/24, C12N 9/14, A61Q 11/02, A61Q 11/00, A61K 8/66
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14705554

PERMEATION ENHANCED ACTIVE-CARRYING NANOPARTICLES

IPC classification:
A61K 9/51, B82Y 5/00, A61K 47/48, A61K 9/14
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14708315

NANOPARTICLE DELIVERY COMPOSITIONS

IPC classification:
A61P 25/00, B82Y 5/00, A61K 9/51, A61K 49/18, A61K 47/48, A61K 9/00
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14705555

NANOPARTICLE PEPTIDE COMPOSITIONS

IPC classification:
A61P 3/08, A61K 47/48
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14705556

NANOPARTICLE PEPTIDE COMPOSITIONS

IPC classification:
A61P 19/08, A61K 47/48
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14703082

DISCRIMINATION OF BLOOD TYPE VARIANTS

IPC classification:
C12Q 1/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14702243

GENETIC MARKERS FOR OSTEOARTHRITIS

IPC classification:
C12Q 1/68
Agent:
SugraƱes Patentes y Marcas
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14779926

THERAPEUTIC COMPOSITIONS COMPRISING EXTRACTS OF PROPOLIS AND USES THEREOF

IPC classification:
A61P 35/00, A61K 31/353, A61K 31/235, A61K 31/216, A61K 31/12
Applicant:
Manuka Health New Zealand Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14779790

THERAPEUTIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61P 1/00, A61P 35/00, A61K 47/40, A61K 35/64
Applicant:
Manuka Health New Zealand Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14807782

METHODS AND USES OF SLIT FOR TREATING FIBROSIS

IPC classification:
A61P 19/04, A61P 13/12, A61K 38/17
Applicant:
The Hospital For Sick Children
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13176407

Perhydrolase

IPC classification:
C11D 3/386, C12N 9/52, C12N 9/50, C12N 9/16
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13165442

Alpha-glucanase and oral care composition containing the same

IPC classification:
C12N 9/24, C12N 9/14, A61Q 11/02, A61Q 11/00, A61K 8/66
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15727759

ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 38/16
Applicant:
University of Oregon
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16195863

DENTAL LIGHT USING LEDS

IPC classification:
F21Y 105/10, F21Y 115/10, F21W 131/202, F21V 21/30, F21V 21/26
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15822404

PROPOLIS AND EXTRACTS THEREOF FOR THE TREATMENT OF SKIN CANCERS AND IMPROVEMENT OF SKIN HEALTH

IPC classification:
A61P 35/00, A61K 47/40, A61K 35/644, A61K 31/353, A61K 31/216
Applicant:
Manuka Health New Zealand Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15741290

A METHOD FOR DETECTING A GENETIC VARIANT

IPC classification:
G06F 19/18, C12Q 1/68
Applicant:
Cancer Research Technology Ltd
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15750052

CONSENSUS-BASED ALLELE DETECTION

IPC classification:
C12Q 1/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15775552

PROTEINS INCREASING PANCREATIC BETA CELL NUMBER AND METHODS OF USE

IPC classification:
C12N 5/071, C07K 14/195, A61K 38/00
Applicant:
University of Oregon
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15790736

SERINE PROTEASES OF BACILLUS SPECIES

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15791844

SERINE PROTEASES

IPC classification:
C07K 14/47
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15790777

SERINE PROTEASES

IPC classification:
C11D 3/386, C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15794695

SERINE PROTEASES

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15794158

SUSTAINED RELEASE ENCAPSULATED NANOPARTICLES

IPC classification:
A61K 9/51, A61K 47/50, A61K 9/16, A61K 47/34, A61K 9/00
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15820158

NANOPARTICLES AND THEIR USE IN CANCER THERAPY

IPC classification:
A61P 35/00, A61K 47/50
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP16710971

METHODS, TOOLS AND SYSTEMS FOR THE ASSESSMENT, PREVENTION, MANAGEMENT AND TREATMENT SELECTION FOR TYPE 2 DIABETES

IPC classification:
C12Q 1/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP16715309

NANOPARTICLE-BASED ANTIGEN SPECIFIC IMMUNOTHERAPY

IPC classification:
A61P 5/48, A61P 3/10, C07K 5/02, A61K 38/28, A61K 38/20, A61K 38/18, A61K 51/12
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP16794331

DIAGNOSTIC METHODS AND DEVICES

IPC classification:
B01L 3/00, C12Q 1/68
Applicant:
University of the Basque Country (Euskal Herriko Unibertsitatea (UPV/EHU))
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP17205190

GLUCOAMYLASE VARIANTS WITH ALTERED PROPERTIES

IPC classification:
C12P 7/06, C12P 19/14, C12P 19/02, C12N 15/80, C12N 1/15, C12N 15/56, C12N 9/34
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP17715654

CYCLODEXTRIN-PANOBINOSTAT ADDUCT

IPC classification:
A61K 47/40, A61K 47/69
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature